CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
or paclitaxel (cohort 1) or with sacituzumab govitecan-hziy (cohort 2) in patients with non-surgically removable locally advanced or metastatic triple...
Phase 2
Salt Lake City, Utah, United States and 44 other locations
oral immuno-oncology product candidate targeting immune-suppressive tumor-associated myeloid cells through selective inhibition of phosphoin ...
Phase 2
Salt Lake City, Utah, United States and 23 other locations
escalation will be open to the enrollment of patients diagnosed with triple-negative breast cancer or ovarian cancer...
Phase 1
Salt Lake City, Utah, United States and 1 other location
or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after su...
Phase 3
Salt Lake City, Utah, United States and 160 other locations
with previously untreated, locally advanced inoperable or metastatic triple-negative breast cancer, whose tumors...
Phase 3
Salt Lake City, Utah, United States and 505 other locations
This study is to evaluate the safety and tolerability of JAB-2485 monotherapy in adult participants with advanced solid tumors....
Phase 1, Phase 2
Salt Lake City, Utah, United States and 4 other locations
This study will test the safety of a drug called PF-08046054/SGN-PDL1V alone and with pembrolizumab in participants with solid tumors. It wi ...
Phase 1
West Valley City, Utah, United States and 23 other locations
and antitumor activity of PRO1107 in patients with advanced solid tumors. This study consists of 2 parts, Part A: dose escalation and dose l...
Phase 1, Phase 2
Salt Lake City, Utah, United States and 3 other locations
This study will test the safety, including side effects, and determine the characteristics of a drug called PRO1184 in participants with solid tumors...
Phase 1, Phase 2
West Valley City, Utah, United States of America and 31 other locations
preliminary antitumor activity of NKT3447 in adult subjects with cyclin E1 (CCNE1) amplified ovarian cancer at the RDEs selected in Dose Es...
Phase 1
West Valley City, Utah, United States of America and 7 other locations
Clinical trials
Research sites
Resources
Legal